Lee Y S, Wurster R D
Department of Neurological Surgery, Loyola University Medical Center, Maywood, IL 60153.
Cancer Lett. 1994 Apr 1;78(1-3):19-23. doi: 10.1016/0304-3835(94)90026-4.
The interactions of nitric oxide (NO) and ascorbate were explored on the control of growth of human brain tumor cells. Sodium nitroprusside, a NO-generating agent, inhibited the growth of SK-N-MC human neuroblastoma cells in a dose-dependent manner. The growth inhibitory effect of nitroprusside was potentiated by sodium ascorbate and inhibited by hemoglobin. Ascorbate-induced potentiation was also observed in U-373 MG human astrocytoma cells. In both tumor cell lines, this potentiation was blocked by catalase, suggesting that hydrogen peroxide may be involved in the potentiation mechanism. In astrocytoma cells, mannitol or deferoxamine also reversed ascorbate-induced potentiation, indicating involvement of hydroxyl radical. These results suggest that the combined treatment with nitroprusside and ascorbate may be a valuable therapeutic strategy for brain tumors.
研究了一氧化氮(NO)与抗坏血酸盐在控制人脑肿瘤细胞生长方面的相互作用。硝普钠是一种NO生成剂,它以剂量依赖的方式抑制SK-N-MC人神经母细胞瘤细胞的生长。硝普钠的生长抑制作用被抗坏血酸钠增强,被血红蛋白抑制。在U-373 MG人星形细胞瘤细胞中也观察到抗坏血酸盐诱导的增强作用。在这两种肿瘤细胞系中,这种增强作用被过氧化氢酶阻断,表明过氧化氢可能参与了增强机制。在星形细胞瘤细胞中,甘露醇或去铁胺也能逆转抗坏血酸盐诱导的增强作用,表明羟自由基参与其中。这些结果表明,硝普钠和抗坏血酸盐联合治疗可能是一种有价值的脑肿瘤治疗策略。